Incyte Corporation

NCT07780838

CollaboratorPhase 2Recruiting29 people24 Aug 2026clinicaltrials.gov

Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

CollaboratorPhase 1Recruiting40 people23 Apr 2026clinicaltrials.gov

NCT07228624

CollaboratorPhase 2Recruiting50 people14 Nov 2025clinicaltrials.gov

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

CollaboratorPhase 2Recruiting190 people25 May 2025clinicaltrials.gov

NCT06752694

CollaboratorPhase 2Active, not recruiting1 person31 Dec 2024clinicaltrials.gov

NCT06416800

Phase 1Completed71 people16 May 2024clinicaltrials.gov

NCT06160791

CollaboratorPhase 2Recruiting54 people7 Dec 2023clinicaltrials.gov

NCT05453500

CollaboratorPhase 2Active, not recruiting32 people12 Jul 2022clinicaltrials.gov

NCT04859946

CollaboratorPhase 2Active, not recruiting31 people26 Apr 2021clinicaltrials.gov

NCT04824092

Phase 3Active, not recruiting899 people1 Apr 2021clinicaltrials.gov

NCT04551131

CollaboratorPhase 1/2Active, not recruiting10 people16 Sept 2020clinicaltrials.gov

NCT04205812

Phase 3Completed583 people19 Dec 2019clinicaltrials.gov

NCT04203511

Phase 3Withdrawn0 people18 Dec 2019clinicaltrials.gov

NCT04161248

CollaboratorEarly phase 1Active, not recruiting40 people13 Nov 2019clinicaltrials.gov

NCT03878199

CollaboratorPhase 1/2Terminated12 people18 Mar 2019clinicaltrials.gov

NCT03773107

CollaboratorPhase 1/2Completed12 people12 Dec 2018clinicaltrials.gov

NCT03656536

Phase 3Terminated167 people4 Sept 2018clinicaltrials.gov

NCT03571321

CollaboratorPhase 1Recruiting15 people27 Jun 2018clinicaltrials.gov

NCT03358472

Phase 3Completed89 people30 Nov 2017clinicaltrials.gov

NCT03348904

Phase 3Terminated2 people21 Nov 2017clinicaltrials.gov